Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
1
Proposed Changes to Meaningful Use 1 & 2
Paul Kleeberg, MD, FAAFP, FHIMSS
CMIO Stratis Health
2
Objectives
• Provide an overview of the proposed changes to stages 1 and 2 of the Meaningful Use program starting this year
• Enable you to understand what you may need to start now or do differently
• Help you to plan for 2016 and beyond
3
Meaningful Use Overview: Statutory Framework
• In HITECH, Congress established three fundamental criteria of requirements for meaningful use:
– Use of certified EHR technology in a meaningful manner
– The exchange of health information
– Submission of clinical quality data Adapted from: Brian Wagner, Senior Director of Policy and Public Affairs, eHealth Initiative (eHI)
presentation to the MN Exchange and Meaningful Use Workgroup January 15, 2010
4
4
Bending the Curve Towards Transformed Health
Data capture and sharing
Advanced clinical
processes
Improved outcomes
Stage 1 Stage 2
Stage 3
“Phased-in series of improved
clinical data capture supporting
more rigorous and robust quality
measurement and improvement.”
Source: Connecting for Health, Markle Foundation “Achieving
the Health IT Objectives of the American Recovery and
Reinvestment Act” April 2009
5
The Proposed Rule
• Meaningful Use Changes to Stage 1 and 2
– Released: April 15, 2015 and available in html at:
https://www.federalregister.gov/articles/2015/04/15/2015-08514/medicare-and-medicaid-programs-electronic-health-record-incentive-program-modifications-to
– Comments closed: June 15, 2015
6
Proposed Timeline Changes for MU 1-2
• 90 Day reporting for all in 2015 • Providers scheduled to do MU1
– In 2015 will do MU2 with additional exemptions – In 2016 and 2017 will do MU 2 without additional exemptions
• Starting in 2017, Medicare first timers must do a full year (Medicaid only may do any 90 days)
X 2 X X X
90 days 90 days
* Still considered doing stage 2 even if they did stage 1
X 2
7
Reporting Periods
• 2015 – Hospitals
Starting in 2015 and continuing on have a calendar reporting year 15 reporting months in the 2015 year but only need to attest for
90 continuous days)
– Professionals Any 90 days in calendar year 2015
• 2016 – Any 90 days for first time attesters – Full year for those beyond their first year
• 2017 and later – Full year reporting for all except Medicaid only first year
8
Attestation
• No changes to the method • All Medicare
– No 2015 Medicare attestations before January 2016 – New exception:
Hospitals in their first year may attest to 2015 before August 15 if they contact Elizabeth Holland ([email protected]) at the Division of Health IT at CMS and provide the hospital name, CMS Certification Number and contact person information
• Deadlines – Last day of February for all
• Medicaid – Providers who fall below 30% (or 20%) threshold, can attest under
Medicare to avoid the penalty without it constituting a switch in payment programs
9
Incentives
• Unchanged but winding down • Medicare
– If just starting 2014 was last year for EP to attest and begin to receive incentives 2015 is last year for CAH or PPS hospitals attest and begin to receive incentives
– Last incentive payment year: 2015 for CAHs 2016 for EPs and PPS hospitals
• Medicaid – If just starting
2016 is last year for EPs, CAH or PPS hospitals to receive incentives
– EPs 2021 is last payment year for EPs Max of 6 payments
– Hospitals Last possible payment year depends on the state – can be 3-6 years after 1st payment Any payment skipped after 2016 ends the program
10
Penalties and Exceptions
• Unchanged Except
– All who attest for the first time anytime in 2015 will not be penalized in either 2016 or 2017
The attestation system will not be available before January 2016 except as noted in the attestation slide
– All who attest for first time in 2016 will not be penalized in 2017 and 2018 if they attest before Oct 1 2016
– 2017 and later requires full year reporting
11
Miscellaneous Changes
• State Flexibility
– Unchanged
• Paper-based documents
– No longer count in numerators starting in 2015 except for patient education materials
12
Proposed Program Goals and Objectives
• Protect Patient Health Information • Electronic Prescribing • Clinical Decision Support • Computerized Provider Order Entry • Patient Electronic Access to Health
Information • Health Information Exchange • Public Health and Clinical Data Registry
Reporting
13
Changes to Stage 1: 2015-17
Measure Stage 1 2014 Stage 1 2015 Stage 1 2016-17
Security Risk Analysis C Y/N C Y/N C Y/N
eRx (EP) C 40% C 40% C 50%
Drug Formulary (EP) M Y/N Exclusion Exclusion C Y/N
eRx with Formulary (EH) C 10%
CDS C 1 C 1 C 5
Drug Interactions C Y/N C Y/N C Y/N
Medications C 30% C 30% C 60%
labs C 30%
Radiology C 30%
Patient Ed M 10% C 10% C 10%
Have access to VDT C 50% C 50% C 50%
Actually VDT C Y/N
Secure messages C Y/N
eSummary of Care C 10%
Med Rec M 50% C 50% C 50%
Immunization Registry M Y/N
EP:
1 of 5
EH:
2 of 6
Y/N
EP:
2 of 5
EH:
3 of 6
Y/N
Syndromic Surveillance M Y/N Y/N Y/N
Case Reporting Y/N Y/N
Public Health Registry Y/N Y/N
Clinical Data Registry Y/N Y/N
Reportable Labs (EH) M Y/N Y/N Y/N
14
Changes to Stage 2: 2015-17
Measure Stage 2 2014 Stage 2 2015 Stage 2 2016-17
Security Risk Analysis C Y/N C Y/N C Y/N
ePrescribing (EP) C 50% C 50% C 50%
Drug Formulary (EP) C Y/N C Y/N C Y/N
eRx with Formulary (EH) M 10% M 10% C 10%
CDS C 5 C 5 C 5
Drug Interactions C Y/N C Y/N C Y/N
Medications C 60% C 60% C 60%
Labs C 30% C 30% C 30%
Radiology C 30% C 30% C 30%
Patient Ed C 10% C 10% C 10%
Have access to VDT C 50% C 50% C 50%
Patients Use VDT C 5% C 1 patient C 1 patient
Secure messages C 5% C Enabled C 1 patient
eSummary of Care C 10% C 10% C 10%
Med Rec C 50% C 50% C 50%
Immunization Registry C Y/N
EP: 2
of 5
EH: 3
of 6
Y/N
EP: 3
of 5
EH: 4
of 6
Y/N
Syndromic Surveillance EP: M
EH: C Y/N Y/N Y/N
Case Reporting Y/N Y/N
Public Health Registry Y/N Y/N
Clinical Data Registry Y/N Y/N
Reportable Labs (EH) C Y/N Y/N Y/N
15
Protect Personal Health Information
Stage 1 (Core)
• Measure
– Conduct or review a security risk analysis, implement security updates as necessary and correct identified security deficiencies
• Denominator
– Yes/No Attest
• Exclusion
– None
Stage 2 (Core)
• Measure – Conduct or review a
security risk analysis, including the encryption/security of data stored in CEHRT, implement security updates as necessary and correct identified security deficiencies
• Denominator – Yes/No Attest
• Exclusion – None
15
Proposed
• Unchanged except:
– Implies that it is expanded to include all instances of electronically stored PHI not just on CEHRT
16
Drug Formulary Check
Stage 1 (Menu)
• Measure – Implement drug
formulary checks with at least one internal or external formulary
• Denominator – Yes/No Attest
• Exclusion – EP: writes <100
medication orders during the EHR reporting period
– EH: None
Stage 2 (Core/Menu)
• Measure
– EP: Incorporated into the eRx core item
– EH: Incorporated into the eRx menu item
16
Proposed
• 2015
– Incorporated into the Stage 2 eRx item for EPs & EHs
17
ePrescribing (EP)
Stage 1 (Core)
• Measure – >40% of permissible
scripts are generated and transmitted electronically
• Denominator – Number of permissible
(non-controlled substance) scripts written by the EP
• Exclusion – Any EP who writes <100
prescriptions during the EHR reporting period.
– No pharmacies that accept e-prescriptions within 10 miles
Stage 2 (Core)
• Measure – >50 percent of permissible
or all prescriptions written are queried for a drug formulary and transmitted electronically
• Denominator – Number of permissible or
all scripts written by the EP
• Exclusion – Any EP who writes <100
permissible prescriptions during the EHR reporting period.
– No pharmacies that accept e-prescriptions within 10 miles
17
Proposed
• Stage 1 – Unchanged for 2015 only
– Stage 2 requirement in 2016 & 2017
• Stage 2 – Unchanged
18
Discharge ePrescribing (EH)
Stage 1
• None
Stage 2 (Menu)
• Measure – >10 percent of hospital
discharge medication orders for permissible prescriptions are queried for a drug formulary and transmitted electronically.
• Denominator – Number of new, changed,
and refilled prescriptions
• Exclusion – No internal pharmacy that
can accept electronic prescriptions
– Not located within 10 miles of any pharmacy that accepts electronic prescriptions
18
Proposed
• Stage 1 – Not required in 2015 only
– Stage 2 requirement in 2016 & 2017
• Stage 2 – Not required in 2015 only
– Required element in 2016 & 2017
19
Clinical Decision Support (CDS)
Stage 1 (Core)
• Measures (were separate)
– 1 CDS rule relevant to the specialty specific quality metric or high priority condition with the ability to track compliance
• Denominator
– Yes/No Attest
• Exclusion
– None
Stage 2 (Core)
• Measures
– 5 CDS interventions relevant to 4 quality metrics or high priority condition
• Denominator
– Yes/No Attest
• Exclusion
– None
19
Proposed
• Stage 1
– Unchanged for 2015 only
– Stage 2 requirement in 2016 & 2017
• Stage 2
– Unchanged
20
Drug-Drug and Drug-Allergy Interaction Checks
Stage 1 (Core)
• Measure
– This functionality is enabled for the entire EHR reporting period
• Denominator
– Yes/No Attest
• Exclusion
– None
Stage 2 (Core)
• Measure
– This functionality is enabled for the entire EHR reporting period
• Denominator
– Yes/No Attest
• Exclusion
– EP: if writes <100 medication orders
20
Proposed
• Stage 1&2
– Unchanged
21
Computerized Provider Order Entry (CPOE)
Stage 1 (Core)
• Measure – >30% of patients on
any meds with ≥ one CPOE med order or may use >30% all orders
• Denominator – Unique patients or
unique orders)
• Exclusion: – Any EP who writes
<100 medication orders during the EHR reporting period.
Stage 2 (Core)
• Measures – >60% of all medication
orders, >30% of all laboratory and >30% radiology orders must be entered using CPOE
• Denominators: – Unique orders
• Exclusions: – Any EP who writes <100
medication, <100 radiology, or <100 laboratory orders during the EHR reporting period.
21
Proposed
• Stage 1
– Unchanged for 2015 only
– Stage 2 requirement in 2016 & 2017
• Stage 2
– Unchanged
Any licensed healthcare professionals and credentialed medical assistants, can enter orders into the medical record for
purposes of including the order in the numerator for the objective of CPOE if they can originate the order per state, local and
professional guidelines.
22
Patient Education
Stage 1 (Menu)
• Measure
– >10% of all unique patients are provided patient- specific education resources identified by Certified EHR Technology.
• Denominator
– Unique patients
• Exclusion
– None
Stage 2 (Core)
• Measure
– >10% of all unique patients are provided patient- specific education resources identified by Certified EHR Technology.
• Denominator
– Unique patients
• Exclusion
– EP: No office visits
– EH: None
22
Proposed
• Stage 1
– May claim exclusion in 2015 only
• Stage 2
– Unchanged
– Paper still counts
• Denominator
– Unique patients
• Exclusion
– EP: No office visits
– EH: None
23
Online Access to Health Information: Measure 1
Stage 1 Core
• Measure – >50% are provided
timely online access to their health information within 4 business days of it being available
• Denominator – Unique patients
• Exclusion – EP: Creates no
information, except for “Patient name” and “Provider's name” and office contact information.
Stage 2 (Core)
• Measure – >50% are provided
timely online access to their health information within 4 business days of it being available
• Denominator – Unique patients
• Exclusion – EP: Creates no
information, except for “Patient name” and “Provider's name” and office contact information.
23
Proposed
• Stage 1&2
– Unchanged
24
Online Access to Health Information: Elements
Professionals • Required elements
– Patient name – Provider's name contact info. – Current and past problem list. – Procedures. – Laboratory test results. – Current med list & med history. – Current med allergies & med allergy history. – Vital signs (height, weight, blood pressure,
BMI, growth charts). – Smoking status. – Demographic information (preferred
language, sex, race, ethnicity, date of birth). – Care plan field(s), including goals and
instructions. – Any known care team members including
the primary care provider (PCP) of record.
Hospitals • Required elements
– Patient name. – Admit & discharge date and location. – Reason for hospitalization. – Care team including the attending of record
and other providers of care. – Procedures performed during admission. – Current and past problem list. – Vital signs at discharge. – Laboratory test results (available at time of
discharge). – Summary of care record for transitions of
care or referrals to another provider. – Care plan field(s), including goals and
instructions. – Discharge instructions for patient. – Demographics maintained by hospital (sex,
race, ethnicity, date of birth, preferred language).
– Smoking status.
24
25
Online Access to Health Information: Measure 2
Stage 1
• None
Stage 2 Core
• Measure – >5% view, download, or
transmit (VDT) their health information
• Denominator – Unique patients
• Exclusions – EP: Creates no information,
except for “Patient name”, “Provider's name” and office contact information
– ALL: ≥50% encounters in a county with <50% of its housing units have 3 Mbps broadband http://www.broadbandmap.
gov/
25
Proposed
• Stage 1 – May be excluded in 2015
– Stage 2 requirement in 2016 & 2017
• Stage 2 – Required attesting that
one patient has done it
• Exclusion – Unchanged except now 4
Mbps broadband
26
Secure Electronic Messaging
Stage 1
• None
Stage 2 (Core) EP
• Measure – >5% of unique patients
(or their representatives) seen by the EP during the reporting period send the EP a secure message.
• Denominator – Unique patients
• Exclusion – No office visits
– ≥50% encounters in a county with <50% percent of its housing units have 3 Mbps broadband
26
Proposed EP & EH
• Stage 1 – May be excluded in 2015
– Stage 2 for 2016 & 2017
• Stage 2 – Required attesting that
capability is fully enabled
• Exclusion – Unchanged except now 4
Mbps broadband
27
Summary of Care / Referral
Stage 1 (Menu)
• Measure
– >50% of referrals and transitions of care
• Denominator
– Care transitions
• Exclusion
– EP: Does not refer or transition
– EH: None
Stage 2 (Core)
• Measure – >50% of referrals and
transitions of care
– >10% sent electronically
– One or more sent electronically to: A different provider with
a different EMR
The CMS designated test EHR
• Denominator – Care transitions
• Exclusion – EP: <100
transfers/referrals during the EHR reporting period
– EH: None
27
Proposed
• Stage 1 – May claim exclusion in
2015 only
– Stage 2 requirement in 2016 & 2017
• Stage 2 – SoC is created with
CEHRT and >10% eExchanged
• Denominator – Unchanged
• Exclusion – Unchanged
28
Summary of Care / Referral: Elements
• Patient name. • Referring or transitioning provider’s
name and contact information. • Procedures. • Encounter diagnosis. • Immunizations. • Laboratory test results. • Vital signs (height, weight, blood
pressure, BMI). • Smoking status. • Functional status, including
activities of daily living, cognitive and disability status.
• Demographic information (preferred language, sex, race, ethnicity, date of birth).
• Care plan field, including goals and instructions.
• Care team including the primary care provider of record and any additional known care team members beyond the referring or transitioning provider and the receiving provider.
• Reason for referral / Discharge instructions
• Current problem list (may also include historical problems).
• Current medication list. • Current medication allergy list.
29
Medication Reconciliation
Stage 1 (Menu)
• Measure – >50% of transitions of
care or a relevant encounter
• Denominator – # of transitions of care
(and relevant encounters if there is a policy)
• Exclusion – EP: No transitions of
care or referrals received
– EH: None
Stage 2 (Core)
• Measure – >50% of transitions of
care or a relevant encounter
• Denominator – # of transitions of care
(and relevant encounters if there is a policy)
• Exclusion – EP: No transitions of
care or referrals received
– EH: None
29
Proposed
• Stage 1
– May be excluded 2015
– Stage 2 requirement in 2016 & 2017
• Stage 2
– Unchanged
30
Public Health (PH) & Clinical Data Registry (CDR) Reporting
• Proposed Objective: – Active engagement with a Public Health Agency (PHA) or clinical
data registry (CDR) to submit electronic public health.
• Active Engagement: – Completed Registration to Submit Data:
Application submitted with 60 days of reporting period Awaiting invitation to test and validate
– Testing and Validation: EP/EH must respond to requests to test within 30 days
– Production: Active submission of data
• Exclusions – Agencies need to be capable at the start of the reporting period
31
PH & CDR Reporting Options
Measure
EP: Maximum Times
Measure Can Count • Stage 1 2015: Choose 1,
2016 on: Choose 2
• Stage 2: Choose 2
EH: Maximum Times
Measure Can Count • Stage 1 2015: Choose 2,
2016 on: Choose 3
• Stage 2: Choose 3
Immunization Registry
Reporting 1 1
Syndromic Surveillance
Reporting 1 1
Case Reporting 1 1
Public Health Registry
Reporting 3 4
Clinical Data Registry
Reporting 3 4
Electronic Reportable
Laboratory Results N/A 1
32
PH/CDR: Submit to Immunization Registry
Stage 1 (Menu)
• Measure – ≥ 1 test of submission
to state immunization registry except where prohibited with continued submission if successful
• Denominator – Yes/No Attest
• Exclusions – Administers no
immunizations
– No registry with the capacity to receive
Stage 2 (Core)
• Measure – Successful ongoing
submission of electronic immunization data to an immunization registry or information system for the entire EHR reporting period
• Denominator – Yes/No Attest
• Exclusion – Administers no
immunizations – No registry with the
capacity to receive
32
Proposed
• Measure
– Active engagement with a public health agency to submit immunization data and receive immunization forecasts and histories
• Denominator
– Unchanged
• Exclusion
– Unchanged
33
PH/CDR: Syndromic Surveillance
Stage 1 (Menu)
• Measure – ≥ 1 test of submission
to a public health agency except where prohibited with continued submission if successful
• Denominator – Yes/No Attest
• Exclusions – Not in a category of
providers who collect this data
– No agency with the capacity to receive
Stage 2 (EP: Menu; EH: Core) • Measure
– Successful ongoing submission to a public health agency for the entire EHR reporting period
• Denominator – Yes/No Attest
• Exclusion – EP: Not in a category of
providers who collect this data
– EH: No Emergency/Urgent Care
– No agency with the capacity to receive
33
Proposed
• Measure
– Active engagement with a public health agency to submit immunization syndromic surveillance data
• Denominator
– Unchanged
• Exclusion
– Unchanged
34
PH/CDR: Case Reporting
Stage 1 & 2
• None
Proposed • Measure:
– Active engagement with a public health agency to submit case reporting of reportable conditions as defined by the state, territorial, and local PHAs to monitor disease trends and support management of outbreaks.
• Denominator – Attest yes/no
• Exclusion: – EP does not diagnose any reportable
diseases for which data is collected
– No PHA with the capacity to receive
34
35
PH/CDR: Cancer Registry (EP)
Stage 1
• None
Stage 2 (Menu)
• Measure – Successful ongoing
submission of cancer case information to a public health central cancer registry for the entire EHR reporting period.
• Denominator – Attest yes/no
• Exclusion: – EP does not diagnose
or directly treat cancer; – No PHA with the
capacity to receive electronic cancer case information
35
Proposed
• Measure:
– No longer specifically identified
36
PH/CDR: Public Health Registry Reporting (may do more than one)
Stage 1
• None
Stage 2 (Menu)
• Measure – Successful on-going
submission of specific case information to a specialized registry for the entire EHR reporting period.
• Denominator – Attest yes/no
• Exclusion: – EP does not diagnose
or treat relevant diseases;
– The EP operates in a jurisdiction for which no public health agency is capable
36
Proposed
• Measure:
– Active engagement with a public health agency to submit relevant data to public health registries
• Denominator
– Attest yes/no
• Exclusion:
– Does not diagnose or treat relevant diseases;
– No PHA with the capacity to receive
37
PH/CDR: Clinical Data Registry Reporting (may do more than one)
Stage 1
• None
Stage 2 (Menu)
• Measure – Successful on-going
submission of specific case information to a specialized registry for the entire EHR reporting period.
• Denominator – Attest yes/no
• Exclusion: – Does not diagnose or
treat relevant diseases;
– No registry with the capacity to receive
37
Proposed
• Measure: – Active engagement to
submit relevant data to a clinical data registry
– Defined: A record of the health status of patients with relevant diseases & the care they receive over time
• Denominator – Attest yes/no
• Exclusion: – Does not diagnose or
treat relevant diseases; – No registry with the
capacity to receive
38
PH/CDR: Reportable Labs (EH)
Stage 1 (Menu)
• Measure – ≥ 1 test of submission
to a public health agency except where prohibited with continued submission if successful
• Denominator – Attest yes/no
• Exclusion: – Does not order
reportable labs;
– No PHA with the capacity to receive
Stage 2 (Core)
• Measure – Successful ongoing
submission to a public health agency for the entire EHR reporting period
• Denominator – Attest yes/no
• Exclusion: – Does not order
reportable labs;
– No PHA with the capacity to receive
38
Proposed
• Measure:
– Active engagement with a public health agency to submit electronic reportable lab results.
• Denominator
– Unchanged
• Exclusion
– Unchanged
39
Deleted from Stage 1: 2015
Measure Stage 1 2014 Stage 1 2015 - 17
Summary of Care Any Method M 50% Exclusion 2015, eSoC after
Demographics C 50% (eAccess & eSoC)
Vital Signs C 50% (eAccess & eSoC)
Problem List C 80% (eAccess & eSoC)
Medication List C 80% (eAccess & eSoC)
Allergies C 80% (eAccess & eSoC)
Smoking C 50% (eAccess & eSoC)
Incorporate Labs M 40% (eAccess & eSoC)
Clinical Summaries (EP) C 50% (eAccess)
Advanced Directives (EH) M 50% Not Measured
Patient Lists M Y/N Not Measured
Patient Reminders (EP) M 20% Not Measured
40
Deleted from Stage 2: 2015-17
Measure Stage 2 2014 Stage 2 2015 on
Summary of Care Any Method C 50% (eSoC)
eSoC Diff EHR & system C Y/N (eSoC)
Provider Notes M 30% (eAccess & eSoC)
Demographics C 80% (eAccess & eSoC)
Vital Signs C 80% (eAccess & eSoC)
Smoking C 80% (eAccess & eSoC)
Incorporate Labs C 55% (eAccess & eSoC)
Clinical Summaries (EP) C 50 (eAccess)
Imaging Results M 10% Not Measured
Family History M 20 Not Measured
Advanced Directives (EH) M 50% Not Measured
Provide eLab Results (EH) M 20% Not Measured
eMAR (EH) C 10% Not Measured
Patient Lists C Y/N Not Measured
Patient Reminders (EP) C 10% Not Measured
41
Demographics
Stage 1 (Core)
• Measure
– >50% of patients seen: preferred language, gender, race, ethnicity, and DOB. For EHs: date and preliminary cause of death
• Denominator
– Unique Patients
• Exclusion
– None
Stage 2 (Core)
• Measure
– >80% of patients seen: preferred language, sex, race, ethnicity, DOB. For EHs: date and preliminary cause of death
• Denominator
– Unique Patients
• Exclusion
– None
41
Proposed
• Mandatory element in
– Online Access to Health Information
– Summary of Care
• No longer reported separately
42
Vital Signs
Stage 1 (Core)
• Measure – >50% of patients ≥ 2yo
seen: height, weight, BP, BMI, & for age 2-20: growth charts w/BMI. May split BP and height-weight, also may use only ≥ 3 for BP and all ages for H/W/BMI)
• Denominator – Unique patients
• Exclusion – EP: If outside scope of
practice – EH: None
Stage 2 (Core)
• Measure – >80% of patients
height/length, weight, BMI; ≥ 3yo: BP; age 0-20: growth charts w/BMI. May split BP and height/length-weight
• Denominator – Unique Patients
• Exclusion – EP: If BP or H/L-W is
outside scope of practice
– EH: None
42
Proposed
• Mandatory element in
– Online Access to Health Information
– Summary of Care
• No longer reported separately
43
Problem List
Stage 1 (Core)
• Measure
– >80% of patients seen at least one or “none” as structured data
• Denominator
– Unique patients
• Exclusion
– None
Stage 2
• Measure
– Incorporated as a mandatory element in the transfer of care document
• Denominator
– Referrals or transfers of care
• Exclusion
– None
43
Proposed
• Mandatory element in
– Online Access to Health Information
– Summary of Care
• No longer reported separately
44
Medication List
Stage 1 (Core)
• Measure
– >80% of patients seen at least one or “none” as structured data
• Denominator
– Unique patients
• Exclusion
– None
Stage 2
• Measure
– Incorporated as a mandatory element in the transfer of care document
• Denominator
– Referrals or transfers of care
• Exclusion
– None
44
Proposed
• Mandatory element in
– Online Access to Health Information
– Summary of Care
• No longer reported separately
45
Medication Allergies
Stage 1 (Core)
• Measure
– >80% of patients seen at least one or “none” as structured data
• Denominator
– Unique patients
• Exclusion
– None
Stage 2
• Measure
– Incorporated as a mandatory element in the transfer of care document
• Denominator
– Referrals or transfers of care
• Exclusion
– None
45
Proposed
• Mandatory element in
– Online Access to Health Information
– Summary of Care
• No longer reported separately
46
Smoking Status
Stage 1 (Core)
• Measure
– >50% of patients ≥ 13yo seen, record status as structured data
• Denominator
– Unique patients
• Exclusion
– No patients 13 years old or older.
Stage 2 (Core)
• Measure
– >80% of patients ≥ 13yo seen, record status as structured data
• Denominator
– Unique patients
• Exclusion
– No patients 13 years old or older.
46
Proposed
• Mandatory element in
– Online Access to Health Information
– Summary of Care
• No longer reported separately
47
Family Health History
Stage 1
• None
Stage 2 (Menu)
• Measure
– >20% have a structured data entry for one or more first-degree relatives
• Denominator
– Unique patients
• Exclusion
– EH: None
– EP: No office visits
47
Proposed
• Measure
– Not reported
– Not an element in SoC or eAccess
48
Advanced Directives (EH)
Stage 1 (Menu)
• Measure
– >50% of ≥65yo admitted indicate advanced directive recorded
• Denominator
– Unique inpatient admissions
• Exclusion
– No patients ≥65yo admitted
Stage 2 (Menu)
• Measure
– >50% of ≥65yo admitted indicate advanced directive recorded
• Denominator
– Unique inpatient admissions
• Exclusion
– No patients ≥65yo admitted
48
Proposed
• Measure
– Not reported
– Not an element in SoC or eAccess
49
Electronic Medication Tracking eMAR (EH)
Stage 1
• None
Stage 2 (Core)
• Measure – >10 percent of
medication orders (includes all doses) are tracked from order to administration using eMAR.
• Denominator – Medication orders
• Exclusion – EH/CAH with average
daily census <10 patients
49
Proposed
• Measure
– Not reported
– Not an element in SoC or eAccess
50
Electronic Provider Notes
Stage 1
• None
Stage 2 (Menu)
• Measure – >30% of unique
patients have at least one electronic progress note created, edited and signed by an authorized provider. The text must be text searchable and may contain drawings and other content
• Denominator – Unique patients
• Exclusion – None
50
Proposed:
• Potentially appear in
– Online Access Care Plan Field
– Discharge Instructions (EH)
– Reason for Referral (EP)
• No longer reported separately
51
Imaging Results
Stage 1
• None
Stage 2 (Menu)
• Measure – >10 percent of all tests
whose result is one or more images are accessible through Certified EHR Technology
• Denominator – Imaging studies
• Exclusion – EP: Orders <100 imaging
studies during the EHR reporting period or without access to electronic imaging results at the start of the EHR reporting period.
– EH: None
51
Proposed
• Measure
– Not reported
– Not an element in SoC or eAccess
52
Incorporate Lab Results
Stage 1 (Menu)
• Measure
– >40% of labs with numeric or +/- result in chart as structured data
• Denominator
– Unique +/- or numeric lab results
• Exclusion
– EP: No results of this type ordered
– EH: None
Stage 2 (Core)
• Measure
– >55% of labs with numeric or +/- result in chart as structured data
• Denominator
– Unique +/- or numeric lab results
• Exclusion
– EP: No results of this type ordered
– EH: None
52
Proposed
• Mandatory element in
– Online Access to Health Information
– Summary of Care
• No longer reported separately
53
Patient Lists
Stage 1 (Menu)
• Measure
– Generate at least one pt list based on a specific condition
• Denominator
– Yes/No Attest
• Exclusion
– None
Stage 2 (Core)
• Measure
– Generate at least one pt list based on a specific condition
• Denominator
– Yes/No Attest
• Exclusion
– None
53
Proposed
• Measure
– Not reported
– Could be considered an element of quality measurement
54
Provide Electronic Lab Results (EH)
Stage 1
• None
Stage 2 (Menu)
• Measure – >20 percent of
electronic lab orders received, Hospital labs send structured electronic clinical lab results to the ordering provider
• Denominator – Electronic lab orders
received
• Exclusion – None
54
Proposed
• Measure
– Not required
• No longer reported separately
55
Clinical Summaries (EP)
Stage 1 (Core)
• Measure
– >50% of office visits, a patient gets a visit summary within 3 business days
• Denominator
– Office Visits
• Exclusion
– No office visits during the EHR reporting period
Stage 2 (Core)
• Measure
– >50% of office visits, a patient or their representative gets a visit summary within 1 business day
• Denominator
– Office Visits
• Exclusion
– No office visits during the EHR reporting period
55
Proposed
• Potentially appear in
– Online Access Care Plan Field includes goals & instructions
• Paper no longer tracked
• No longer reported separately
56
Patient Reminders (EP)
Stage 1 (Menu)
• Measure
– >20% of pts ≥ 65 or ≤ 5yo sent reminders for follow up care
• Denominator
– Unique Patients
• Exclusion
– No patients ≥ 65 or ≤ 5yo
Stage 2 (Core)
• Measure – >10% pts with >1
office visit within 2 years receive reminders for follow-up care sent per patient preference.
• Denominator – Unique patients with
2 or more visits in past 24 months
• Exclusion – No office visits in 24
months before the measurement period
56
Proposed
• Measure
– Not reported
57
• Eligible Professional – Record Demographics – Record Vital Signs – Record Smoking Status – Clinical Summaries – Structured Lab Results – Patient List – Patient Reminders – Summary of Care Measure
• Any Method Measure • Test different vendor and system
– Electronic Notes – Imaging Results – Family Health History
• Eligible Hospital/CAH – Record Demographics – Record Vital Signs – Record Smoking Status – Structured Lab Results – Patient List – Summary of Care Measure
• Any Method Measure • Test different vendor and system
– eMAR – Advanced Directives – Electronic Notes – Imaging Results – Family Health History – Structure Labs to Ambulatory
Providers
Eliminated as Separate Measures
58
CEHRT
• Use 2014 or 2015 Certified EHR Technology (CEHRT) or a combination through 2017 for MU 1 & 2
59
CQM Reporting
• Same method, domain requirements and number as for 2014 • 2015
– Any 90 days in the calendar year – EHs, additional 3 months at end of CY 2014 (15 month reporting
year) – Can be more than 90 days and does not need to correspond with
MU objective reporting period
• 2016 – Full year reporting except first year MU
• 2017 – Full year reporting for all except first year Medicaid only – May attest to 2016 measures or e-submit to 2017 measures
60
What to Expect
• Final rule in September or October – MU2 NPRM released 3/7/12, comments closed
5/6/12 – MU2 Final Rule released 9/4/12 – 4 months later – MU 1&2 Revisions NPRM comments closed 6/15
4 months later is October
• Therefore – Proceed with all current requirements – Plan for potential new requirements in 2015 – Prepare for a full year of MU2 in 2016
61
Questions?
Paul Kleeberg, MD
CMIO Stratis Health [email protected]
This material was prepared by Telligen, the Quality Innovation Network
National Coordinating Center, under contract with the Centers for
Medicare & Medicaid Services (CMS), an agency of the U.S. Department
of Health and Human Services. The contents presented do not necessarily
reflect CMS policy. (11SOW-QINNCC-00325-07/13/15)